These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15479908)

  • 1. Small vessel vasculitis and relapsing panniculitis in tumour necrosis factor receptor associated periodic syndrome (TRAPS).
    Lamprecht P; Moosig F; Adam-Klages S; Mrowietz U; Csernok E; Kirrstetter M; Ahmadi-Simab K; Schroder JO; Gross WL
    Ann Rheum Dis; 2004 Nov; 63(11):1518-20. PubMed ID: 15479908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor receptor-associated periodic fever syndrome in a 58-year-old man: caution not to discount TRAPS as a diagnosis in older patients.
    Sinožić D; Toplak N; Milotić I
    J Clin Rheumatol; 2011 Sep; 17(6):325-8. PubMed ID: 21869706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment.
    Stojanov S; Dejaco C; Lohse P; Huss K; Duftner C; Belohradsky BH; Herold M; Schirmer M
    Ann Rheum Dis; 2008 Sep; 67(9):1292-8. PubMed ID: 18180277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): state of the art and future perspectives.
    Cantarini L; Lucherini OM; Muscari I; Frediani B; Galeazzi M; Brizi MG; Simonini G; Cimaz R
    Autoimmun Rev; 2012 Nov; 12(1):38-43. PubMed ID: 22884554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A.
    Nowlan ML; Drewe E; Bulsara H; Esposito N; Robins RA; Tighe PJ; Powell RJ; Todd I
    Rheumatology (Oxford); 2006 Jan; 45(1):31-7. PubMed ID: 16287931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment with infliximab of a patient with tumor necrosis factor-associated periodic syndrome (TRAPS) who failed to respond to etanercept.
    Krelenbaum M; Chaiton A
    J Rheumatol; 2010 Aug; 37(8):1780-2. PubMed ID: 20675856
    [No Abstract]   [Full Text] [Related]  

  • 7. [TRAPS syndrome, a rare cause of fever of unknown origin: case report and review of the literature].
    Benucci M; Nenci G; Taccetti G; Rosso A; Cappelletti C
    Ann Ital Med Int; 2005; 20(1):54-7. PubMed ID: 15859396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A Dutch family with the hereditary periodic fever or tumour necrosis factor receptor-associated periodic syndrome (TRAPS)].
    Chang Pan Huo NM; Dankert-Roelse JE; Kwee ML
    Ned Tijdschr Geneeskd; 2006 Dec; 150(49):2711-4. PubMed ID: 17194009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients.
    Drewe E; McDermott EM; Powell PT; Isaacs JD; Powell RJ
    Rheumatology (Oxford); 2003 Feb; 42(2):235-9. PubMed ID: 12595616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two familial cases with tumor necrosis factor receptor-associated periodic syndrome caused by a non-cysteine mutation (T50M) in the TNFRSF1A gene associated with severe multiorganic amyloidosis.
    Kallinich T; Briese S; Roesler J; Rudolph B; Sarioglu N; Blankenstein O; Keitzer R; Querfeld U; Haffner D
    J Rheumatol; 2004 Dec; 31(12):2519-22. PubMed ID: 15570662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mutation (T61I) in the gene encoding tumour necrosis factor receptor superfamily 1A (TNFRSF1A) in a Japanese patient with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) associated with systemic lupus erythematosus.
    Ida H; Kawasaki E; Miyashita T; Tanaka F; Kamachi M; Izumi Y; Huang M; Tamai M; Origuchi T; Kawakami A; Migita K; Motomura M; Yoshimura T; Eguchi K
    Rheumatology (Oxford); 2004 Oct; 43(10):1292-9. PubMed ID: 15280569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of cyclosporine A treatment in relapsing febrile lobular panniculitis associated with small vessel vasculitis.
    Cantarini L; Fanti F; Galeazzi M; Martino S; Miracco C; Biagioli M; Dal Canto N; Cimaz R
    Rheumatol Int; 2010 Apr; 30(6):797-9. PubMed ID: 19506878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Periodic fever" without fever: two cases of non-febrile TRAPS with mutations in the TNFRSF1A gene presenting with episodes of inflammation or monosymptomatic amyloidosis.
    Kallinich T; Haffner D; Rudolph B; Schindler R; Canaan-Kühl S; Keitzer R; Burmester GR; Roesen-Wolff A; Roesler J
    Ann Rheum Dis; 2006 Jul; 65(7):958-60. PubMed ID: 16308343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late-onset tumor necrosis factor receptor-associated periodic syndrome in multiple sclerosis patients carrying the TNFRSF1A R92Q mutation.
    Kümpfel T; Hoffmann LA; Rübsamen H; Pöllmann W; Feneberg W; Hohlfeld R; Lohse P
    Arthritis Rheum; 2007 Aug; 56(8):2774-83. PubMed ID: 17665448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of sustained response to etanercept and refractoriness to anakinra in patients with T50M TNF-receptor-associated periodic syndrome.
    Quillinan N; Mannion G; Mohammad A; Coughlan R; Dickie LJ; McDermott MF; McGonagle D
    Ann Rheum Dis; 2011 Sep; 70(9):1692-3. PubMed ID: 21378401
    [No Abstract]   [Full Text] [Related]  

  • 16. The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder.
    Hull KM; Drewe E; Aksentijevich I; Singh HK; Wong K; McDermott EM; Dean J; Powell RJ; Kastner DL
    Medicine (Baltimore); 2002 Sep; 81(5):349-68. PubMed ID: 12352631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene.
    Ravet N; Rouaghe S; Dodé C; Bienvenu J; Stirnemann J; Lévy P; Delpech M; Grateau G
    Ann Rheum Dis; 2006 Sep; 65(9):1158-62. PubMed ID: 16569687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome.
    Drewe E; Huggins ML; Morgan AG; Cassidy MJ; Powell RJ
    Rheumatology (Oxford); 2004 Nov; 43(11):1405-8. PubMed ID: 15316120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Setting up TRAPS.
    Pettersson T; Kantonen J; Matikainen S; Repo H
    Ann Med; 2012 Mar; 44(2):109-18. PubMed ID: 21284532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent migratory angioedema as cutaneous manifestation in a familiar case of TRAPS: dramatic response to Anakinra.
    Cattalini M; Meini A; Monari P; Gualdi G; Arisi M; Pelucchi F; Bolognini S; Gattorno M; Calzavara-Pinton PG; Plebani A
    Dermatol Online J; 2013 Nov; 19(11):20405. PubMed ID: 24314780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.